107 related articles for article (PubMed ID: 11905848)
1. Preservation of enzyme activity and antigenicity after mutagenesis of the membrane anchoring domain of GAD65.
Plesner A; Hampe CS; Daniels TL; Hammerle LP; Lernmark A
Autoimmunity; 2001; 34(4):221-30. PubMed ID: 11905848
[TBL] [Abstract][Full Text] [Related]
2. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
[TBL] [Abstract][Full Text] [Related]
3. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase.
Schwartz HL; Chandonia JM; Kash SF; Kanaani J; Tunnell E; Domingo A; Cohen FE; Banga JP; Madec AM; Richter W; Baekkeskov S
J Mol Biol; 1999 Apr; 287(5):983-99. PubMed ID: 10222205
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.
Hampe CS; Hammerle LP; Falorni A; Robertson J; Lernmark A
FEBS Lett; 2001 Jan; 488(3):185-9. PubMed ID: 11163769
[TBL] [Abstract][Full Text] [Related]
5. The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65.
Kanaani J; Lissin D; Kash SF; Baekkeskov S
J Biol Chem; 1999 Dec; 274(52):37200-9. PubMed ID: 10601283
[TBL] [Abstract][Full Text] [Related]
6. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
[TBL] [Abstract][Full Text] [Related]
7. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling.
Myers MA; Davies JM; Tong JC; Whisstock J; Scealy M; Mackay IR; Rowley MJ
J Immunol; 2000 Oct; 165(7):3830-8. PubMed ID: 11034389
[TBL] [Abstract][Full Text] [Related]
8. Conformation-dependent GAD65 autoantibodies in diabetes.
Luo D; Gilliam LK; Greenbaum C; Bekris L; Hampe CS; Daniels T; Richter W; Marcovina SM; Rolandsson O; Landin-Olsson M; Kockum I; Lernmark A
Diabetologia; 2004 Sep; 47(9):1581-91. PubMed ID: 15365614
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of GAD antigenicity.
Arafat Y; Fenalti G; Whisstock JC; Mackay IR; Garcia de la Banda M; Rowley MJ; Buckle AM
Mol Immunol; 2009 Dec; 47(2-3):493-505. PubMed ID: 19783309
[TBL] [Abstract][Full Text] [Related]
10. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling.
O'Connor KH; Banga JP; Darmanin C; El-Kabbani O; Mackay IR; Rowley MJ
J Autoimmun; 2006 May; 26(3):172-81. PubMed ID: 16564157
[TBL] [Abstract][Full Text] [Related]
12. GAD65 as a prototypic autoantigen.
Fenalti G; Rowley MJ
J Autoimmun; 2008 Nov; 31(3):228-32. PubMed ID: 18514483
[TBL] [Abstract][Full Text] [Related]
13. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
Richter W; Shi Y; Baekkeskov S
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
[TBL] [Abstract][Full Text] [Related]
14. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
15. A signal located within amino acids 1-27 of GAD65 is required for its targeting to the Golgi complex region.
Solimena M; Dirkx R; Radzynski M; Mundigl O; De Camilli P
J Cell Biol; 1994 Jul; 126(2):331-41. PubMed ID: 8034738
[TBL] [Abstract][Full Text] [Related]
16. Structural model of human GAD65: prediction and interpretation of biochemical and immunogenic features.
Capitani G; De Biase D; Gut H; Ahmed S; Grütter MG
Proteins; 2005 Apr; 59(1):7-14. PubMed ID: 15690345
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.
Fenalti G; Hampe CS; O'connor K; Banga JP; Mackay IR; Rowley MJ; El-Kabbani O
Mol Immunol; 2007 Feb; 44(6):1178-89. PubMed ID: 16930708
[TBL] [Abstract][Full Text] [Related]
18. Autoantigenic reactivity of diabetes sera with a hybrid glutamic acid decarboxylase GAD67-65 molecule GAD67(1-101)/GAD65(96-585).
Teoh KL; Fida S; Rowley MJ; Mackay IR
Autoimmunity; 1998; 28(4):259-66. PubMed ID: 9892508
[TBL] [Abstract][Full Text] [Related]
19. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
[TBL] [Abstract][Full Text] [Related]
20. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
